Clémence Ramier

ORCID: 0000-0002-1928-0263
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Cannabis and Cannabinoid Research
  • Alcohol Consumption and Health Effects
  • Substance Abuse Treatment and Outcomes
  • Diet, Metabolism, and Disease
  • Liver Disease and Transplantation
  • Hepatitis B Virus Studies
  • COVID-19 and Mental Health
  • HIV/AIDS Research and Interventions
  • Mindfulness and Compassion Interventions
  • HIV-related health complications and treatments
  • HIV, Drug Use, Sexual Risk
  • Smoking Behavior and Cessation
  • Liver Diseases and Immunity
  • Diabetes and associated disorders
  • Mental Health and Patient Involvement
  • Sleep and related disorders
  • Psychological Well-being and Life Satisfaction
  • Multiple Sclerosis Research Studies
  • Forensic Toxicology and Drug Analysis
  • Mental Health Treatment and Access
  • Diabetes Management and Education
  • Nutritional Studies and Diet
  • Bipolar Disorder and Treatment

Inserm
2021-2025

Institut de Recherche pour le Développement
2021-2025

Economic & Social Sciences, Health Systems & Medical Informatics
2021-2025

Aix-Marseille Université
2021-2024

We read with great interest the recent paper from Martín-Carmona et al., who found that HIV does not increase mortality risk after hepatitis C virus (HCV) cure direct-acting antivirals (DAA) in people advanced liver fibrosis [1].By publishing long-term followup data, authors provide valuable insights into unresolved question of whether or increases HCV cure.

10.1093/cid/ciaf016 article EN other-oa Clinical Infectious Diseases 2025-01-13

ABSTRACT Background and Aims Early assessment of hepatocellular carcinoma (HCC) risk could improve long‐term outcomes in people with chronic hepatitis B virus (HBV) infection. Some existing HCC predictive scores are not easily implementable. We developed easy‐to‐use based on behavioural routine bio‐clinical data HBV Methods Eight‐year follow‐up was analysed from infection enrolled the French ANRS CO22 HEPATHER cohort. Patients were randomly split into two samples (training/testing). A...

10.1111/liv.70065 article EN cc-by-nc-nd Liver International 2025-03-15

Abstract Background Cannabidiol (CBD), a safe, non-intoxicating cannabis component, is growing in popularity Europe and worldwide. However, CBD EU regulation blurry, consequent labelling product quality issues may have implications for public health. There therefore need to assess the prevalence perceived harmfulness of use countries, as well characterise users. We aimed do so French population. Methods In December 2021, an online survey was conducted sample respecting adult population...

10.1186/s12889-022-14057-0 article EN cc-by BMC Public Health 2022-08-29

People living with chronic hepatitis B virus (HBV) infection are at high risk of liver disease progression, which is positively associated metabolic disorders, but inversely dyslipidemia. Diet, including dietary antioxidants, a lever disorder management. In particular, elevated coffee consumption different outcomes in the general population. We aimed to test whether such associations occur HBV-infected people. Based on cross-sectional data from ANRS CO22 Hepather cohort, we performed...

10.3390/antiox11020379 article EN cc-by Antioxidants 2022-02-14

Background and Aims. Hepatitis C virus (HCV) infection is associated with the onset of metabolic disorders which constitute risk factors for liver disease progression. Their impact may persist after HCV has been cured. Cannabis use a lower obesity diabetes in both general populations. The associations between cannabis dyslipidemia hypertension have not yet studied persons chronic infection. Methods. Using cross-sectional data from French ANRS CO22 Hepather cohort, we used regression models...

10.3390/jcm11206135 article EN Journal of Clinical Medicine 2022-10-18
Tangui Barré Stanislas Pol Clémence Ramier Vincent Di Beo Fabrice Carrat and 95 more Morgane Bureau Marc Bourlière Céline Dorival Lawrence Serfaty Tarik Asselah Jérôme Boursier Fabienne Marcellin Patrizia Carrieri Hélène Fontaine Camélia Protopopescu Laurent Alric Delphine Bonnet Virginie Payssan-Sicart Chloe Pomes Fabien Zoulim Marianne Maynard Roxane Bai Lucie Hucault François Bailly François Raffi Eric Billaud D. Boutoille Maeva Lefebvre Elisabeth André‐Garnier Paul Calès I. Hubert Adrien Lannes F. Lunel Nathalie Boyer Nathalie Giuily Corinne Castelnau Giovanna Scoazec Emilie Rousseaud Anaïs Vallet‐Pichard Philippe Sogni Victor de Lédinghen Juliette Foucher Jean‐Baptiste Hiriart Jancell M’Bouyou Marie Irlès-Depé Si Nafa Si Ahmed Valérie Oulès Albert Tran Rodolphe Anty Ève Gelsi Régine Truchi Dominique Thabut Saloua Hammeche Joseph Moussali Xavier Causse Barbara De Dieuleveult Brahim Ouarani Damien Labarrière Nathalie Ganne‐Carrié Véronique Grando–Lemaire Pierre Nahon Séverine Brulé Betul Ulker Dominique Guyader Caroline Jézéquel Audrey Brener Anne Laligant Aline Rabot Isabelle Renard François Habersetzer Thomas F. Baumert Michel Doffoël Catherine Schmidt‐Mutter Pauline Simo‐Noumbissie Esma Razi Jean-Pierre Bronowicki Hélène Barraud Mouni Bensenane Abdelbasset Nani Sarah Hassani-Nani Marie-Albertine Bernard Georges‐Philippe Pageaux Dominique Larrey M Mészáros Sophie Métivier Christophe Bureau Thibault Morales Jean Marie Péron Marie Angèle Robic Thomas Decaens Marine Faure Bruno Froissart Marie‐Noëlle Hilleret Jean–Pierre Zarski Ghassan Riachi Odile Goria Fatima Paris Hélène Montialoux Vincent Leroy Giuliana Amaddeo

Background: Chronic hepatitis B virus (HBV) infection may evolve into cirrhosis and hepatocellular carcinoma, this progression be accelerated by specific risk factors, including overweight obesity. Although evidence for a protective effect of cannabis use on elevated body weight has been found other populations, no data are available HBV-infected patients. Aims: We aimed to identify factors (including use) obesity in patients with HBV chronic infection. Methods: Using baseline from the...

10.1089/can.2021.0094 article EN Cannabis and Cannabinoid Research 2021-10-14

Therapeutic patient education (TPE) aims to help people with chronic disease strengthen their empowerment and psychosocial skills better manage condition. Although TPE has great potential for addiction medicine, studies on its benefits reducing alcohol-related harms increasing are sparse. We conducted a qualitative study of alcohol use disorder (AUD) who participated in the community-based programme Choizitaconso assess perceptions experiences it. Semi-structured interviews were 16...

10.3390/ijerph19159228 article EN International Journal of Environmental Research and Public Health 2022-07-28
Patrizia Carrieri Marc Bourlière Vincent Di Beo Clovis Lusivika‐Nzinga Clémence Ramier and 95 more Saskia Antwerpes Camélia Protopopescu Jean‐Marc Lacombe Stanislas Pol Hélène Fontaine Abbas Mourad Fabrice Carrat Martin Duracinský Fabienne Marcellin Laurent Alric Delphine Bonnet Océane Camou Fabien Zoulim Marianne Maynard François Bailly Bénédicte Poumaroux Miroslava Subic F. Raffi Éric Billaud D. Boutoille Maeva Lefebvre Elisabeth André‐Garnier Paul Calès I. Hubert Clémence M. Canivet F. Lunel Jérôme Boursier Tarik Asselah Nathalie Boyer Nathalie Giuily Corinne Castelnau Giovanna Scoazec Stanislas Pol Hélène Fontaine Lucia Parlati Emilie Rousseaud Anaïs Vallet‐Pichard Philippe Sogni Victor de Lédinghen Juliette Foucher Jean‐Baptiste Hiriart Paul Hermabessière Marie Irlès-Depé Marc Bourlière Si Nafa Si Ahmed Valérie Oulès Rania Kibeche Albert Tran Rodolphe Anty Ève Gelsi Régine Truchi Dominique Thabut Saloua Hammeche Joseph Moussali Xavier Causse Barbara De Dieuleveult Brahim Ouarani Damien Labarrière Magali Jeulin Nathalie Ganne‐Carrié Véronique Grando–Lemaire Pierre Nahon Séverine Brulé Lucie Del Pozo Caroline Jézéquel Audrey Brener François Habersetzer Thomas F. Baumert Lawrence Serfaty Pauline Simo‐Noumbissie Alexandre Bolle Jean‐Pierre Bronowicki Mouni Bensenane-Oussalah Vincent Haghnejad Sébastien Daude Sarah Hadj-Rhouma Georges‐Philippe Pageaux Dominique Larrey M Mészáros Sophie Métivier Christophe Bureau Thibault Morales Jean Marie Péron Hélène Larrue Thomas Decaens Marie‐Noëlle Hilleret Charlotte Costentin Bleuenn Brusset Agnès Bonadona Ghassan Riachi Odile Goria Fatima Paris Hélène Montialoux Vincent Leroy Giuliana Amaddeo

10.1007/s11136-023-03496-w article EN Quality of Life Research 2023-08-16

Background Relationships between mindfulness and general craving have been documented. However, there is still no data regarding relationships the different factors.Methods Using from an online survey among hospital workers smoking tobacco in France (n = 127), we performed linear regression models with four factors as outcomes, dispositional explanatory variable.Results After adjusting for nicotine dependence, was negatively associated three out of (emotionality, compulsivity purposefulness,...

10.1080/10826084.2021.2019782 article EN Substance Use & Misuse 2021-12-27

ABSTRACT Although Hepatitis C virus (HCV) infection can be cured with direct‐acting antivirals (DAA), some patients face a serious risk of advanced liver damage and early mortality. In order to avoid these two negative health outcomes, it is important identify assess related factors. Little currently known about socioeconomic behavioural factors in this context. Using data from the ANRS CO22 Hepather cohort, we tested for associations between (i) fibrosis (defined as an FIB‐4 > 3.25)...

10.1111/jvh.14006 article EN cc-by-nc Journal of Viral Hepatitis 2024-09-10

Abstract Introduction Alcohol use disorder (AUD) is associated with a significant disease burden in France, where alcohol deeply rooted culture. However, the treatment gap large because of several barriers, including stigmatisation and drinkers' apprehension about total abstinence. standardised evidence‐based interventions based on controlled‐drinking for people AUD are lacking. We aimed to assess effectiveness novel community‐based French therapeutic patient education (TPE) program named...

10.1111/dar.13605 article EN cc-by-nc-nd Drug and Alcohol Review 2023-01-31
Tangui Barré Fabrice Carrat Clémence Ramier Hélène Fontaine Vincent Di Beo and 95 more Morgane Bureau Céline Dorival Dominique Larrey Elisabeth Delarocque‐Astagneau Philippe Mathurin Fabienne Marcellin Ventzislava Petrov–Sanchez Carole Cagnot Patrizia Carrieri Stanislas Pol Camélia Protopopescu Laurent Alric Chloe Pomes Fabien Zoulim Marianne Maynard Roxane Bai Lucie Hucault François Bailly F. Raffi Eric Billaud D. Boutoille Maeva Lefebvre Elisabeth André‐Garnier Paul Calès I. Hubert Adrien Lannes F. Lunel Jérôme Boursier Tarik Asselah Nathalie Boyer Nathalie Giuily Corinne Castelnau Giovanna Scoazec Stanislas Pol Hélène Fontaine Emilie Rousseaud Anaïs Vallet‐Pichard Philippe Sogni Victor de Lédinghen Juliette Foucher Jean‐Baptiste Hiriart Jancell M’Bouyou Marie Irlès-Depé Marc Bourlière Si Nafa Si Ahmed Valérie Oulès Albert Tran Rodolphe Anty Ève Gelsi Régine Truchi Dominique Thabut Saloua Hammeche Joseph Moussali Xavier Causse Barbara De Dieuleveult Brahim Ouarani Damien Labarrière Nathalie Ganne‐Carrié Véronique Grando–Lemaire Pierre Nahon Séverine Brulé Betul Ulker Dominique Guyader Caroline Jézéquel Audrey Brener Anne Laligant Aline Rabot Isabelle Renard François Habersetzer Thomas F. Baumert Michel Doffoël Catherine Schmidt‐Mutter Pauline Simo‐Noumbissie Esma Razi Jean-Pierre Bronowicki Hélène Barraud Mouni Bensenane Abdelbasset Nani Sarah Hassani-Nani Marie-Albertine Bernard Georges‐Philippe Pageaux Dominique Larrey M Mészáros Sophie Métivier Christophe Bureau Thibault Morales Jean Marie Péron Marie Angèle Robic Thomas Decaens Marine Faure Bruno Froissart Marie‐Noëlle Hilleret Jean–Pierre Zarski Ghassan Riachi Odile Goria

Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major factor for these disorders, and therefore, managing body weight crucial. Cannabis use, which common in patients, has been associated lower corpulence various populations. However, this relationship not yet studied persons HCV infection.Using baseline data from the French ANRS CO22 Hepather cohort, we used binary logistic multinomial regression models to test an...

10.1186/s42238-022-00138-9 article EN cc-by Journal of Cannabis Research 2022-06-11

Abstract Introduction The risk of mortality in people with a history injection drug use (PHID) is high, as the prevalence hepatitis C virus (HCV) infection. Although direct‐acting antivirals (DAA) are effective this population terms sustained virological response, it not known whether PHID benefit much no from DAA‐related HCV cure reduced all‐cause mortality. Methods Using Cox proportional hazards models based on ANRS CO22 Hepather cohort data ( n = 9735), we identified factors associated...

10.1111/dar.13802 article EN cc-by Drug and Alcohol Review 2023-12-22
Coming Soon ...